LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Scott Weiner is participating on a panel at the Greater Philadelphia Alliance for Capital and Technologies IMPACT 2010 Conference in Philadelphia, PA
News | 11. 09. 2010
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.